783–792. doi:10.1111/j.1469–8749.2011.03980.x. PMID 21518346. S2CID 9951986.

18. Veatch OJ, Pendergast JS, Allen MJ, Leu RM, Johnson CH, Elsea SH, Malow BA (January 2015). “Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay”. Journal of Autism and Developmental Disorders. 45 (1): 100–10. doi:10.1007/s10803–014–2197–4. PMC 4289108. PMID 25059483.

19. Giannotti F, Cortesi F, Cerquiglini A, Bernabei P (August 2006). “An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism”. Journal of Autism and Developmental Disorders. 36 (6): 741–52. doi:10.1007/s10803–006–0116‐z. PMID 16897403. S2CID 19724241.

20. Bendz LM, Scates AC (January 2010). “Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder”. The Annals of Pharmacotherapy. 44 (1): 185–91. doi:10.1345/aph.1M365. PMID 20028959. S2CID 207263711.

21. Melatonin for jet lagDrug and Therapeutics Bulletin 2020;58:21–24. https://dtb.bmj.com/content/58/2/21.long

22. Erland LA, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275–281.

23. Grigg-Damberger MM, Ianakieva D. Poor quality control of over-the-counter melatonin: what they say is often not what you get. J Clin Sleep Med. 2017;13(2):163–165.

24. LeBlanc ES, Perrin N, Johnson JD, Ballatore A, Hillier T. Over-the-Counter and Compounded Vitamin D: Is Potency What We Expect? JAMA Intern Med. 2013;173(7):585–586. doi:10.1001/jamainternmed.2013.3812

25. Gooneratne NS, Edwards AY, Zhou C, Cuellar N, Grandner MA, Barrett JS (May 2012). “Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults”. Journal of Pineal Research. 52 (4): 437–445. doi:10.1111/j.1600–079X.2011.00958.x. PMC 3682489. PMID 22348451.

26. Mohd Rosli RR, Norhayati MN, Ismail SB. Effectiveness of iron polymaltose complex in treatment and prevention of iron deficiency anemia in children: a systematic review and meta-analysis. PeerJ. 2021 Jan 13;9: e10527. doi: 10.7717/peerj.10527. PMID: 33520436; PMCID: PMC7811280.

27. Rogozińska E, Daru J, Nicolaides M, Amezcua-Prieto C, Robinson S, Wang R, Godolphin PJ, Saborido CM, Zamora J, Khan KS, Thangaratinam S. Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis. Lancet Haematol. 2021 Jul;8(7): e503‐e512. doi: 10.1016/S2352–3026(21)00137-X. PMID: 34171281; PMCID: PMC7612251.

28. Guideline: Daily iron supplementation in adult women and adolescent girls. Geneva: World Health Organization; 2016. https://apps.who.int/iris/bitstream/handle/10665/204761/9789241510196_eng.pdf

29. Абдикаримова Р. К. Анализ распространенности железодефицитной анемии в Казахстане // Вестник АГИУВ. 2011. № 3. URL: https://cyberleninka.ru/article/n/analiz-rasprostranennosti-zhelezodefitsitnoy-anemii-v-kazahstane (дата обращения: 05.04.2023).

30. А.Г. Румянцев, И.Н. Захарова, В.М. Чернов, И.С. Тарасова, А.Л. Заплатников, Н.А. Коровина, Т.Э. Боровик, Н.Г. Звонкова, Е.Б. Мачнева, С.И. Лазарева, Т.М. Васильева. Распространенность железодефицитных состояний и факторы, на нее влияющие. Медицинский совет, № 6, 2015 https://remedium.ru/doctor/therapeutics/detail.php? ID=70233

31. Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. JAMA Netw Open. 2018;1(6): e183337. doi:10.1001/jamanetworkopen.2018.3337

32. https://www.rbc.ru/own_business/07/12/2018/5c07ec619a7947168ea0dc6b (дата обращения: 23.10.2023).

33. https://www.nytimes.com/2015/02/07/opinion/herbal-supplements-without-herbs.html (дата обращения: 23.10.2023).

34. Törring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Sääf M, Hamberger B. Graves’ hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine – a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab. 1996 Aug;81(8):2986–93. doi: 10.1210/jcem.81.8.8768863. PMID: 8768863.

35. https://www.ema.europa.eu/en/medicines/national-registers-authorised-medicines

36. https://www.uspnf.com/

37. https://www.newyorker.com/magazine/2013/07/29/slow-ideas?utm_source=NYR_REG_GATE (дата обращения: 23.10.2023).

38. Combe B, Landewe R, Daien CI, et al2016 update of the EULAR recommendations for the management of early arthritis. Annals of the Rheumatic Diseases 2017;76:948–959.

39. Jeremy Howick, Iain Chalmers, Paul Glasziou, Trish Greenhalgh, Carl Heneghan, Alessandro Liberati, Ivan Moschetti, Bob Phillips, and Hazel Thornton. “The 2011 Oxford CEBM Evidence Levels of Evidence (Introductory Document)”. Oxford Centre for Evidence-Based Medicine. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/levels-of-evidence-introductory-document

40. DiNicolantonio J, O’Keefe JH. Does Fish Oil Reduce the Risk of Cardiovascular Events and Death? Recent Level 1 Evidence Says Yes: PRO: Fish Oil is Useful to Prevent or Treat Cardiovascular Disease. Mo Med. 2021 May-Jun;118(3):214–218. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210983/pdf/ms118_p0214.pdf

41. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012 https://pubmed.ncbi.nlm.nih.gov/23235689/

42. Printz, Jonathon O. et al. Conflict of Interest in the Assessment of Hyaluronic Acid Injections for Osteoarthritis of the Knee: An Updated Systematic Review. The Journal of Arthroplasty, Volume 28, Issue 8, 30–33.e1

43. Edlow JA, Smith EE, Stead LG, Gronseth G, Messé SR, Jagoda AS, et al. Clinical policy: use of intravenous tPA for the management of acute ischemic stroke in the emergency department. Ann Emerg Med. 2013;61(2):225–43. doi:10.1016/j.annemergmed.2012.11.005.

44. Lenzer J. Why we can’t trust clinical guidelines. BMJ. 2013;346: f3830. doi:10.1136/bmj.f3830.

45. Lenzer J. Alteplase for stroke: money and optimistic claims buttress the “brain attack” campaign. BMJ. 2002;324(7339):723–9. doi:10.1136/bmj.324.7339.723.

46. Robbins BD, Higgins M, Fisher M, Over K. Conflicts of interest in research on antipsychotic treatment of pediatric bipolar disorder, temper dysregulation disorder, and attenuated psychotic symptoms syndrome: exploring the unholy alliance between big pharma and psychiatry. J Psychol Issues Organ Cult. 2011;1(4):32–49. doi:10.1002/jpoc.20039.

47. Mandeville KL, O’Neill S, Brighouse A, Walker A, Yarrow K, Chan K. Academics and competing interests in H1N1 influenza media reporting. J Epidemiol Community Health. 2013;68(3):197–203. doi:10.1136/jech‐2013–203128.

48. https://briandeer.com/mmr/lancet-summary.htm (дата обращения: 23.10.2023).

49. Dunn, A.G., Coiera, E., Mandl, K.D. et al. Conflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparency. Res Integr Peer Rev 1, 1 (2016). https://doi.org/10.1186/s41073–016–0006–7

50. “Selenium and Vitamin E Cancer Prevention Trial (SELECT): Questions and Answers was originally published by the National Cancer Institute.” https://www.cancer.gov/types/prostate/research/select-trial-results-qa#5 (дата обращения: 23.10.2023).

51. Lippman SM, Goodman PJ, Klein EA, et al. Designing the selenium and vitamin E cancer prevention trial. JNCI 2005; 97(2):94–102.

52. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers. JAMA 2009; 301(1). Published online December 9, 2008. Print edition January 2009.

53. EA Klein, IM Thompson, CM Tangen, et al. Vitamin E and the Risk of Prostate Cancer: Results of The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306(14) 1549–1556.

54. Kim J, Choi J, Kwon SY, McEvoy JW, Blaha MJ, Blumenthal RS, Guallar E, Zhao D, Michos ED. Association of Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7): e004224. doi: 10.1161/CIRCOUTCOMES.117.004224. PMID: 29991644.

55. Jenkins DJA, Spence JD, Giovannucci EL, Kim YI, Josse R, Vieth R, Blanco Mejia S, Viguiliouk E, Nishi S, Sahye-Pudaruth S, Paquette M, Patel D, Mitchell S, Kavanagh M, Tsirakis